340B Under DSCSA: Why a Network is Critical for Efficient 340B Shipping and Receiving

The pharmaceutical and healthcare industry has yet to define a model for handling 340B product under the new DSCSA electronic data exchange mandate. With more than $53 billion in covered drugs purchased annually via the program, this poses a big challenge for the industry.

Join our webinar on April 25 as Elizabeth Waldorf and Dan Walles, two of TraceLink’s leading global traceability and DSCSA experts, explore the different approaches for managing 340B shipments. You’ll get insight into to the specific challenges stakeholders face today, including:

• How new DSCSA mandates impact 340B receiving workflows at contract pharmacies.
• How to eliminate logistical friction between wholesalers and contract pharmacies.
• How to streamline the electronic data exchange process for a fully serialized world.

The DSCSA stabilization period is ending soon! Register for our webinar and ensure your 340B shipping and receiving processes will be ready in time.

67%

No visibility into CMO capacity

52%

No capability to exchange purchase orders in real time